140 related articles for article (PubMed ID: 6502932)
1. [Effect of cefaclor in urinary tract infections (2)].
Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cefaclor on urinary tract infections (the third report)].
Honda M; Kajikawa H; Kameoka H; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1985 Aug; 38(8):2094-107. PubMed ID: 3908732
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cefaclor in urinary tract infections (the first report)].
Hosokawa S; Kajikawa J; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1983 Feb; 36(2):299-310. PubMed ID: 6343662
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of cefaclor for respiratory tract infections].
Hiraga Y; Kikuchi K; Yamamoto A
Jpn J Antibiot; 1984 Apr; 37(4):581-8. PubMed ID: 6471379
[TBL] [Abstract][Full Text] [Related]
5. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
[TBL] [Abstract][Full Text] [Related]
6. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
7. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of S 6472 in urinary tract infection].
Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
[TBL] [Abstract][Full Text] [Related]
9. Therapy with cefaclor: analysis of infections in 189 French patients.
Masbernard A; Salord JC
Postgrad Med J; 1979; 55 Suppl 4():72-6. PubMed ID: 398484
[No Abstract] [Full Text] [Related]
10. Cefaclor versus ampicillin for outpatient treatment of urinary tract infections.
Baraff LJ; Ablon WD
Am J Emerg Med; 1984 Jul; 2(4):327-30. PubMed ID: 6394004
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
[TBL] [Abstract][Full Text] [Related]
14. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
Hayashi I; Ohnuma K
Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cefaclor and amoxycillin in the treatment of urinary infections in a chronic disease hospital.
Lindan R
Postgrad Med J; 1979; 55 Suppl 4():67-9. PubMed ID: 398483
[TBL] [Abstract][Full Text] [Related]
16. Cefaclor: clinical and bacteriological evaluation in 45 cases.
Gómez-Lus R; Martinez-Piriz R; Espinosa C; Guillen G; Gómez-Agudo G; Clavel A
Postgrad Med J; 1979; 55 Suppl 4():70-1. PubMed ID: 44909
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results of cefaclor treatment of infections of oral regions].
Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections].
Aonuma S; Oizumi K; Watanabe A; Tokue Y; Honda Y; Ono R; Kitamura N; Konno K; Satoh K
Jpn J Antibiot; 1988 Sep; 41(9):1309-12. PubMed ID: 3241329
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies of S6472 in otorhinolaryngologic infections].
Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
[TBL] [Abstract][Full Text] [Related]
20. [Cefaclor dosage change with renal dysfunction].
Usuda Y; Sekine O
Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
